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Okada, Kondo, Hoshikawa (left to right)Sendai, JapanPulmonary hypertension (PH) caused by transient leftventricular failure (LVF) is a known complication afterdouble or bilateral lung transplantation (BLTX) for pa-tients with end-stage PH.1,2 In these patients the right
ventricle (RV) becomes large and hypertrophic because of in-
creased pulmonary vascular resistance, whereas the left ventricle
(LV) becomes small and slight because of chronic preload reduc-
tion.3 Normalization of pulmonary vascular resistance by means of
BLTX suddenly increases left ventricular preload, which some-
times leads to a hemodynamic situation susceptible to LVF. Pre-
vention and treatment for this complication primarily consist of
inotropic support and vasodilator therapy to reduce left ventricular
afterload.2 We present here a patient with primary PH who had
repeated PH episodes after BLTX, for which preventative therapy
composed of catecholamines and vasodilators was not effective.
However, the episodes were paradoxically prevented with a
-blocker, propranolol. The clinical course and a possible mech-
anism responsible for the effect of the -blocker are presented.
Clinical Summary
A 39-year-old man complained of dyspnea on exertion in 1996,
and a diagnosis of primary PH was established by means of
echocardiography and cardiac catheterization in July 1997. The
patient was initially treated with oral vasodilators, but deterioration
of right heart failure accompanied by massive ascites and hyper-
bilirubinemia required prostacyclin continuous infusion therapy in
April 1999. Despite prostacyclin dose increment up to 45 ng · kg1
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The Journal of Thoraci· min1 and concomitant inotropic support, he remained in New
York Heart Association class III, and cardiac catheterization in
March 2001 still showed an increased pulmonary artery pressure
(PAP) of 90/35 (mean 52) mm Hg, a decreased cardiac index of
2.07 L · min1 · m2, and a low blood pressure of 81/62 (mean 69)
mm Hg. After 23 months of waiting, he eventually underwent
BLTX from a female donor in November 2001. Surgical interven-
tion and early postoperative course were uneventful, with a PAP of
33/11 (mean 18) mm Hg and a cardiac index of 2.94 L · min1 ·
m2 immediately after the operation. The recipient was deeply
anesthetized with sedatives and a neuromuscular relaxant during
the first 48 hours in an attempt to keep his hemodynamics stable.
Several hours after discontinuation of the neuromuscular relaxant
on day 2 after transplantation, the first episode of PH occurred.
PAP suddenly increased from a baseline of 43/15 (mean 27) mm
Hg to 81/33 (mean 54) mm Hg, and a chest x-ray film immediately
after this episode showed pulmonary edema in both lungs. Imme-
diate increase in the dose of sedatives and resumption of the
neuromuscular relaxant gradually normalized PAP to 27/11 (mean
20) mm Hg. The duration of the PH episode was about 30 minutes.
Because of the concomitant increase in pulmonary capillary wedge
pressure up to 30 mm Hg during this episode, transient LVF was
postulated as the primary cause for PH. Despite inotropic support
with dopamine and dobutamine, aggressive diuresis, and continu-
ous infusion of nitroglycerin, similar transient PH episodes repeat-
edly occurred, with most events being triggered by means of dose
reduction of sedatives or position changes. When analyzing the
hemodynamic alterations in those episodes, we noted that a sudden
increase of PAP and pulmonary capillary wedge pressure was
accompanied by a significant increase in blood pressure and car-
diac output, as shown in Figure 1. These findings made us surmise
that hyperdynamic contraction of the excessively hypertrophic RV,
possibly stimulated by the intrinsic catecholamine release in re-
sponse to some stress to the recipient, would cause volume over-
load to the LV, leading to left ventricular decompensation. On the
basis of this assumption, dopamine and dobutamine were discon-
tinued by day 7 after transplantation, and intermittent injection of
propranolol (approximately 1 mg at a time) was adopted before
dose reduction of sedatives or reduction in ventilatory support.
After this therapeutic conversion on day 7, PH episodes became
minimal and infrequent, if they occurred, and the patient was
successfully extubat
c and Cardiovascued on day 12 after transplantation. The subse-
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Brief Communicationsquent postoperative course was uneventful, and the patient is quite
well, with no activity limitation 26 months after transplantation.
Discussion
Transient LVF after BLTX for PH has previously been described
and perceived to occur on the basis of functional imbalance be-
tween the hypertrophic RV and the LV, with some dysfunction
because of chronic preload reduction.2 By reviewing the hemody-
namic pattern in each PH episode in the present case, we specu-
lated that excessive right ventricular contraction might be the
principal pathogenesis of PH and could be a better target for
treatment rather than left ventricular dysfunction. Consequent dis-
continuation of catecholamines and intermittent use of propranolol
dramatically prevented events of PH and made the subsequent
Figure 1. Hemodynamic alterations before and during
output; mPAP, mean pulmonary artery pressure; PCWP
pressure; LVEF, left ventricular ejection fraction (meas794 The Journal of Thoracic and Cardiovascular Surgery ● Nove-blockers in preventing PH episodes in a carefully selected group
of patients who undergo BLTX for PH, although inotropic support,
aggressive diuresis, and systemic vasodilator therapy remain the
mainstay of treatment for the majority of patients.
References
1. Chapelier A, Vouhe P, Macchiarini P, et al. Comparative outcome of
heart-lung and lung transplantation for pulmonary hypertension. J Tho-
rac Cardiovasc Surg. 1993;106:299-307.
2. Birsan T, Kranz A, Mares P, et al. Transient left ventricular failure
following bilateral lung transplantation for pulmonary hypertension.
J Heart Lung Transplant. 1999;18:304-9.
3. Xie G-Y, Lin CS, Preston HM, et al. Assessment of left ventricular
episode on day 5 after transplantation. CO, Cardiac
lmonary capillary wedge pressure; mBP, mean blood
by means of echocardiography); PA, pulmonary artery.weaning process uneventful. We propose a possible usefulness of
diastolic function after single lung transplantation in patients with
severe pulmonary hypertension. Chest. 1998;114:477-81.a PH
, pumber 2004
